Medicare Part B And Accelerated Approvals: MedPAC Mulls Use Of CED Versus Payment Caps

Medicare advisory panel discusses ongoing issues around launch prices that were not addressed by the government price controls targeting older drugs enacted as part of the Inflation Reduction Act.

Proposed Policy Would Allow Medicare To Essentially Limit Launch Prices • Source: Shutterstock

More from Market Access

More from Pink Sheet